TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...
6h
Workshop on Quantitative Systems Pharmacology Workflows in Pumas™ Created by PumasAI for QSPC 2026
PumasAI, a science-first organization that turns data into life-saving decisions faster, today announced a major presence at ...
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data ...
A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...
FY25 profit surge, discounted valuation, and ReSPECT Phase III Rezzayo catalyst in Q2 2026. Click for this CRMD update.
Montana-based awardees called the terminations ‘devastating’ — and based on a false presumption that tribal initiatives fall ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his ...
Today, President Donald J. Trump imposed tariffs on patented pharmaceuticals and their ingredients under Section 232 of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results